0 Évaluations
ID

4503

Description

ACNS1123 Eligibility Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=

Lien

https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=

Mots-clés

Versions (2)
  1. 09/12/2013 09/12/2013 - Martin Dugas
  2. 02/06/2015 02/06/2015 -
Téléchargé le

9 décembre 2013

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY-NC 3.0 Legacy
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

  • Plus récent
  • Plus ancien
  • Favori
  • Plus récent
    • Plus récent
    • Plus ancien
    • Favori

    Aucun commentaire

    Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

    ACNS1123 Eligibility - 3377519v1.0

    Anglais

    No Instruction available.

    1 Formulaires  
    1. StudyEvent: SE.0000
      1. No Instruction available.
    Stratification
    Description

    Stratification

    ACNS1123 Stratum
    Description

    ClinicalStudyACNS1123StratificationFactorsType

    Type de données

    text

    Study Treatment
    Description

    TreatmentAssignmentType

    Type de données

    text

    Treatment Begin Date (Projected date must be no later than 5 calendar days after the date of study enrollment. Enter as MM/DD/YYYY.)
    Description

    TreatmentBeginDate

    Type de données

    date

    Elig - Block 1
    Description

    Elig - Block 1

    Is the patient enrolled on the ALTE07C1 study?
    Description

    OtherStudyEnrollmentInd-2

    Type de données

    text

    Is the patient greater than or equal to 3 years and less than or equal to 21 years at the time of enrollment?
    Description

    PatientAgeEligibilityDeterminationInd-2

    Type de données

    text

    Was definitive diagnostic surgery performed?
    Description

    FirstDiagnosisFromSurgicalProcedureIndicator

    Type de données

    text

    Date of definitive diagnostic surgery or clinical diagnosis:
    Description

    PersonSuspectedClinicalDiagnosisEligibilityCriteriaDate

    Type de données

    date

    Was lumbar CSF cytology obtained?
    Description

    CerebrospinalFluidCellInd-3

    Type de données

    text

    Was it medically contraindicated? (If no,)
    Description

    CerebrospinalFluidDiagnosticProcedureCytologyContraindicatedInd-2

    Type de données

    text

    Was lumbar CSF cytology negative?
    Description

    LaboratoryProcedureLumbarPunctureCerebrospinalFluidNegativeFindingOutcomeInd-2

    Type de données

    text

    Elig - Block 2
    Description

    Elig - Block 2

    Does patient have germ cell tumor(s) located in the suprasellar, pineal, bifocal (pineal + suprasellar) or ventricles? (Tumors present in the above mentioned locations and with unifocal parenchymal extension)
    Description

    GermCellTumorHistologicClassificationDiagnosisInd-2

    Type de données

    text

    Elig - Block 3
    Description

    Elig - Block 3

    Does patient have newly diagnosed localized primary CNS NGGCT?
    Description

    NewPrimaryMalignantNeoplasmCentralNervousSystemGermCellTumorDiagnosisInd-2

    Type de données

    text

    Does patient have any of the following elements on biopsy/resection? (endodermal sinus tumor yolk sacor embryonal carcinoma or choriocarcinoma or malignant/immature teratoma or mixed GCT with malignant GCT elements)
    Description

    PathologyFindingsIndicator

    Type de données

    text

    Does patient meet any of the following criteria: (Institutional normal AFP and hCGB 5mIU/mL - <= 50mIU/mL in serum and/or CSF or Bifocal pineal + suprasellar involvement or pineal lesion with diabetes insipidus DI AND hCGB<=100mIU/mL and institutional normal AFP in serum/or CSF or Histologically confirmed germinoma mixed with mature teratoma and hCGB <= 100mIU/mL and institutional normal AFP in serum/or CSF.)
    Description

    PatientProtocolRequirementEligibilityDeterminationInd-2

    Type de données

    text

    Elig - Block 4
    Description

    Elig - Block 4

    Does patient have newly diagnosed localized primary CNS germinoma?
    Description

    NewChildhoodBrainGerminomaDiagnosisInd-2

    Type de données

    text

    Does patient meet any of the following criteria: (Institutional normal AFP and hCGB 5mIU/mL - <= 50mIU/mL in serum and/or CSF or Bifocal pineal + suprasellar involvement or pineal lesion with diabetes insipidus DI AND hCGB<=100mIU/mL and institutional normal AFP in serum/or CSF or Histologically confirmed germinoma mixed with mature teratoma and hCGB <= 100mIU/mL and institutional normal AFP in serum/or CSF.)
    Description

    PatientProtocolRequirementEligibilityDeterminationInd-2

    Type de données

    text

    Elig - Block 5
    Description

    Elig - Block 5

    Peripheral absolute neutrophil count (ANC) (number/uL)
    Description

    LaboratoryProcedureAbsoluteNeutrophilCountResultSpecifiedValue

    Type de données

    double

    Unités de mesure
    • ul
    ul
    Platelet count (number/uL): (Transfusion Independent)
    Description

    LaboratoryProcedurePlateletResultSpecifiedValue

    Type de données

    double

    Unités de mesure
    • 1000/uL
    1000/uL
    Hemoglobin(g/dL) (May receive RBC transfusion)
    Description

    LaboratoryProcedureHemoglobinResultSpecifiedValue

    Type de données

    double

    Unités de mesure
    • g/dL
    g/dL
    Elig - Block 5
    Description

    Elig - Block 5

    Creatinine clearance (mL/min/1.73m²):
    Description

    LaboratoryProcedureCreatinineClearanceOutcomeValue

    Type de données

    double

    Radioisotope GFR(mL/min/1.73 m²)
    Description

    LaboratoryProcedureGlomerularFiltrationRateOutcomeSpecifiedValue

    Type de données

    double

    Unités de mesure
    • mL/Min/1.73m2
    mL/Min/1.73m2
    Serum creatinine (mg/dL) (At study entry and based on age/gender per protocol section 3.2.5.2)
    Description

    LaboratoryProcedureCreatinineResultSpecifiedValue

    Type de données

    double

    Unités de mesure
    • mg/dL
    mg/dL
    Elig - Block 7
    Description

    Elig - Block 7

    Total bilirubin (mg/dl), ULN
    Description

    LaboratoryProcedureTotalBilirubinResultSpecifiedUpperLimitofNormalValue

    Type de données

    double

    Unités de mesure
    • mg/dL
    mg/dL
    Total bilirubin Value (mg/dl):
    Description

    LaboratoryProcedureTotalBilirubinResultValue

    Type de données

    double

    Unités de mesure
    • mg/dL
    mg/dL
    SGPT (ALT) or SGOT (AST) U/L, ULN:
    Description

    LaboratoryProcedureSerumGlutamicPyruvicTransaminaseResultUpperLimitofNormalValue

    Type de données

    double

    SGPT (ALT) or SGOT (AST), U/L
    Description

    LaboratoryProcedureAlanineAminotransferaseMeasurementAspartateAminotransferaseMeasurementOutcomeValue

    Type de données

    double

    Elig - Block 8
    Description

    Elig - Block 8

    Does patient have seizure disorder?
    Description

    PatientSeizureDiseaseorDisorderInd-3

    Type de données

    text

    Is patient's seizure disorder well controlled? (Adequate central nervous system function as defined in protocol section 3.2.5.4)
    Description

    NeurologicalEvaluationSeizureSymptomInd-2

    Type de données

    text

    Is patient in status, coma or assisted ventilation at study entry?
    Description

    PatientMechanicalVentilationUseInd-2

    Type de données

    text

    Elig - Block 9
    Description

    Elig - Block 9

    Does patient have mature teratoma with normal tumor markers?
    Description

    PatientCentralNervousSystemGermCellTumorDiagnosisInd-2

    Type de données

    text

    Does patient have tumors located outside the ventricles? (basal ganglia, thalamus)
    Description

    ExternalBrainVentricleCentralNervousSystemGermCellTumorDiagnosisInd-2

    Type de données

    text

    Does patient have metastatic disease by either MRI evaluation or lumbar CSF cytology?
    Description

    MetastaticDiseaseorDisorderMagneticResonanceImagingCerebrospinalFluidDiagnosisInd-2

    Type de données

    text

    Prior to study enrollment, has patient been treated with therapy other than surgical intervention and corticosteroids?
    Description

    SurgicalInterventionCorticosteroidAdministeredInd-2

    Type de données

    text

    Is patient post menarcheal?
    Description

    PediatricEndocrineMensesOnsetInd-2

    Type de données

    text

    Was a pregnancy test performed?
    Description

    PatientPregnancyTestIndicator

    Type de données

    text

    Is patient pregnant? (If yes above,)
    Description

    PatientPregnancyInd-2

    Type de données

    text

    Is patient nursing?
    Description

    PersonBreastFeedingExclusionCriteriaIndicator

    Type de données

    text

    Has patient agreed to stop breastfeeding? (If yes above,)
    Description

    BreastFeedingStopAgreementInd-4

    Type de données

    text

    Has patient agreed to use an effective contraceptive method for the duration of the study participation?
    Description

    ContraceptionAgreementInd

    Type de données

    text

    Elig - Block 10
    Description

    Elig - Block 10

    Date Informed Consent Signed
    Description

    InformedConsentFormSignedDate

    Type de données

    date

    Have all institutional, FDA, and NCI requirements for human studies been met?
    Description

    StudyCompleteRequirementsInd-2

    Type de données

    text

    Comments
    Description

    ResearchCommentsText

    Type de données

    text

    Retour au début de la page

    Similar models

    No Instruction available.

    1 Formulaires
    1. StudyEvent: SE.0000
      1. No Instruction available.
    Name
    Type
    Description | Question | Decode (Coded Value)
    Type de données
    Alias
    Item Group
    Stratification
    CL.1
    Code List
    ACNS1123 Stratum
    CL Item
    Stratum 1 - Nggct (Stratum 1 - NGGCT)
    CL Item
    Stratum 2 - Germinoma (Stratum 2 - Germinoma)
    Item
    Study Treatment
    text
    CL.2
    Code List
    Study Treatment
    CL Item
    Treatment 1: A,b,a,b,a,b (Treatment 1 A B A B A B)
    CL Item
    Treatment 2: A,a,a,a (Treatment 2 A A A A)
    TreatmentBeginDate
    Item
    Treatment Begin Date (Projected date must be no later than 5 calendar days after the date of study enrollment. Enter as MM/DD/YYYY.)
    date
    Item Group
    Elig - Block 1
    Item
    Is the patient enrolled on the ALTE07C1 study?
    text
    CL.3
    Code List
    Is the patient enrolled on the ALTE07C1 study?
    CL Item
    Yes (Yes)
    CL Item
    No (No)
    Item
    Is the patient greater than or equal to 3 years and less than or equal to 21 years at the time of enrollment?
    text
    CL.4
    Code List
    Is the patient greater than or equal to 3 years and less than or equal to 21 years at the time of enrollment?
    CL Item
    Yes (Yes)
    CL Item
    No (No)
    Item
    Was definitive diagnostic surgery performed?
    text
    CL.5
    Code List
    Was definitive diagnostic surgery performed?
    CL Item
    Yes (Yes)
    CL Item
    No (No)
    PersonSuspectedClinicalDiagnosisEligibilityCriteriaDate
    Item
    Date of definitive diagnostic surgery or clinical diagnosis:
    date
    Item
    Was lumbar CSF cytology obtained?
    text
    CL.6
    Code List
    Was lumbar CSF cytology obtained?
    CL Item
    Yes (Yes)
    CL Item
    No (No)
    Item
    Was it medically contraindicated? (If no,)
    text
    CL.7
    Code List
    Was it medically contraindicated? (If no,)
    CL Item
    Yes (Yes)
    CL Item
    No (No)
    CL.8
    Code List
    Was lumbar CSF cytology negative?
    CL Item
    Yes (Yes)
    CL Item
    No (No)
    Item Group
    Elig - Block 2
    Item
    Does patient have germ cell tumor(s) located in the suprasellar, pineal, bifocal (pineal + suprasellar) or ventricles? (Tumors present in the above mentioned locations and with unifocal parenchymal extension)
    text
    CL.9
    Code List
    Does patient have germ cell tumor(s) located in the suprasellar, pineal, bifocal (pineal + suprasellar) or ventricles? (Tumors present in the above mentioned locations and with unifocal parenchymal extension)
    CL Item
    Yes (Yes)
    CL Item
    No (No)
    Item Group
    Elig - Block 3
    Item
    Does patient have newly diagnosed localized primary CNS NGGCT?
    text
    CL.10
    Code List
    Does patient have newly diagnosed localized primary CNS NGGCT?
    CL Item
    Yes (Yes)
    CL Item
    No (No)
    Item
    Does patient have any of the following elements on biopsy/resection? (endodermal sinus tumor yolk sacor embryonal carcinoma or choriocarcinoma or malignant/immature teratoma or mixed GCT with malignant GCT elements)
    text
    CL.11
    Code List
    Does patient have any of the following elements on biopsy/resection? (endodermal sinus tumor yolk sacor embryonal carcinoma or choriocarcinoma or malignant/immature teratoma or mixed GCT with malignant GCT elements)
    CL Item
    Yes (YES)
    CL Item
    No (NO)
    Item
    Does patient meet any of the following criteria: (Institutional normal AFP and hCGB 5mIU/mL - <= 50mIU/mL in serum and/or CSF or Bifocal pineal + suprasellar involvement or pineal lesion with diabetes insipidus DI AND hCGB<=100mIU/mL and institutional normal AFP in serum/or CSF or Histologically confirmed germinoma mixed with mature teratoma and hCGB <= 100mIU/mL and institutional normal AFP in serum/or CSF.)
    text
    CL.14
    Code List
    Does patient meet any of the following criteria: (Institutional normal AFP and hCGB 5mIU/mL - <= 50mIU/mL in serum and/or CSF or Bifocal pineal + suprasellar involvement or pineal lesion with diabetes insipidus DI AND hCGB<=100mIU/mL and institutional normal AFP in serum/or CSF or Histologically confirmed germinoma mixed with mature teratoma and hCGB <= 100mIU/mL and institutional normal AFP in serum/or CSF.)
    CL Item
    Yes (Yes)
    CL Item
    No (No)
    Item
    Does patient have newly diagnosed localized primary CNS germinoma?
    text
    CL.13
    Code List
    Does patient have newly diagnosed localized primary CNS germinoma?
    CL Item
    Yes (Yes)
    CL Item
    No (No)
    Item
    Does patient meet any of the following criteria: (Institutional normal AFP and hCGB 5mIU/mL - <= 50mIU/mL in serum and/or CSF or Bifocal pineal + suprasellar involvement or pineal lesion with diabetes insipidus DI AND hCGB<=100mIU/mL and institutional normal AFP in serum/or CSF or Histologically confirmed germinoma mixed with mature teratoma and hCGB <= 100mIU/mL and institutional normal AFP in serum/or CSF.)
    text
    CL.14
    Code List
    Does patient meet any of the following criteria: (Institutional normal AFP and hCGB 5mIU/mL - <= 50mIU/mL in serum and/or CSF or Bifocal pineal + suprasellar involvement or pineal lesion with diabetes insipidus DI AND hCGB<=100mIU/mL and institutional normal AFP in serum/or CSF or Histologically confirmed germinoma mixed with mature teratoma and hCGB <= 100mIU/mL and institutional normal AFP in serum/or CSF.)
    CL Item
    Yes (Yes)
    CL Item
    No (No)
    LaboratoryProcedureAbsoluteNeutrophilCountResultSpecifiedValue
    Item
    Peripheral absolute neutrophil count (ANC) (number/uL)
    double
    LaboratoryProcedurePlateletResultSpecifiedValue
    Item
    Platelet count (number/uL): (Transfusion Independent)
    double
    LaboratoryProcedureHemoglobinResultSpecifiedValue
    Item
    Hemoglobin(g/dL) (May receive RBC transfusion)
    double
    LaboratoryProcedureCreatinineClearanceOutcomeValue
    Item
    Creatinine clearance (mL/min/1.73m²):
    double
    LaboratoryProcedureGlomerularFiltrationRateOutcomeSpecifiedValue
    Item
    Radioisotope GFR(mL/min/1.73 m²)
    double
    LaboratoryProcedureCreatinineResultSpecifiedValue
    Item
    Serum creatinine (mg/dL) (At study entry and based on age/gender per protocol section 3.2.5.2)
    double
    LaboratoryProcedureTotalBilirubinResultSpecifiedUpperLimitofNormalValue
    Item
    Total bilirubin (mg/dl), ULN
    double
    LaboratoryProcedureTotalBilirubinResultValue
    Item
    Total bilirubin Value (mg/dl):
    double
    LaboratoryProcedureSerumGlutamicPyruvicTransaminaseResultUpperLimitofNormalValue
    Item
    SGPT (ALT) or SGOT (AST) U/L, ULN:
    double
    LaboratoryProcedureAlanineAminotransferaseMeasurementAspartateAminotransferaseMeasurementOutcomeValue
    Item
    SGPT (ALT) or SGOT (AST), U/L
    double
    Item Group
    Elig - Block 8
    Item
    Does patient have seizure disorder?
    text
    CL.15
    Code List
    Does patient have seizure disorder?
    CL Item
    Yes (Yes)
    CL Item
    No (No)
    Item
    Is patient's seizure disorder well controlled? (Adequate central nervous system function as defined in protocol section 3.2.5.4)
    text
    CL.16
    Code List
    Is patient's seizure disorder well controlled? (Adequate central nervous system function as defined in protocol section 3.2.5.4)
    CL Item
    Yes (Yes)
    CL Item
    No (No)
    Item
    Is patient in status, coma or assisted ventilation at study entry?
    text
    CL.17
    Code List
    Is patient in status, coma or assisted ventilation at study entry?
    CL Item
    Yes (Yes)
    CL Item
    No (No)
    Item Group
    Elig - Block 9
    Item
    Does patient have mature teratoma with normal tumor markers?
    text
    CL.18
    Code List
    Does patient have mature teratoma with normal tumor markers?
    CL Item
    Yes (Yes)
    CL Item
    No (No)
    Item
    Does patient have tumors located outside the ventricles? (basal ganglia, thalamus)
    text
    CL.19
    Code List
    Does patient have tumors located outside the ventricles? (basal ganglia, thalamus)
    CL Item
    Yes (Yes)
    CL Item
    No (No)
    Item
    Does patient have metastatic disease by either MRI evaluation or lumbar CSF cytology?
    text
    CL.20
    Code List
    Does patient have metastatic disease by either MRI evaluation or lumbar CSF cytology?
    CL Item
    Yes (Yes)
    CL Item
    No (No)
    Item
    Prior to study enrollment, has patient been treated with therapy other than surgical intervention and corticosteroids?
    text
    CL.21
    Code List
    Prior to study enrollment, has patient been treated with therapy other than surgical intervention and corticosteroids?
    CL Item
    Yes (Yes)
    CL Item
    No (No)
    Item
    Is patient post menarcheal?
    text
    CL.22
    Code List
    Is patient post menarcheal?
    CL Item
    Yes (yes)
    CL Item
    No (no)
    Item
    Was a pregnancy test performed?
    text
    CL.23
    Code List
    Was a pregnancy test performed?
    CL Item
    Yes (Yes)
    CL Item
    No (No)
    Item
    Is patient pregnant? (If yes above,)
    text
    CL.24
    Code List
    Is patient pregnant? (If yes above,)
    CL Item
    Yes (Yes)
    CL Item
    No (No)
    CL.25
    Code List
    Is patient nursing?
    CL Item
    Yes (Yes)
    CL Item
    No (No)
    Item
    Has patient agreed to stop breastfeeding? (If yes above,)
    text
    CL.26
    Code List
    Has patient agreed to stop breastfeeding? (If yes above,)
    CL Item
    Yes (Yes)
    CL Item
    No (No)
    Item
    Has patient agreed to use an effective contraceptive method for the duration of the study participation?
    text
    CL.27
    Code List
    Has patient agreed to use an effective contraceptive method for the duration of the study participation?
    CL Item
    Yes (Yes)
    CL Item
    No (No)
    CL Item
    N/a, Patient Is Not Of Reproductive Potential (NA patient is not of reproductive potential)
    Item Group
    Elig - Block 10
    InformedConsentFormSignedDate
    Item
    Date Informed Consent Signed
    date
    Item
    Have all institutional, FDA, and NCI requirements for human studies been met?
    text
    CL.28
    Code List
    Have all institutional, FDA, and NCI requirements for human studies been met?
    CL Item
    Yes (Yes)
    CL Item
    No (No)
    ResearchCommentsText
    Item
    Comments
    text
    Retour au début de la page 

    Aide

    Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

    Watch Tutorial